Prosecution Insights
Last updated: November 04, 2026
Application No. 18/049,471

IDENTIFICATION OF LIGAND BINDING SITES IN INTRINSICALLY DISORDERED PROTEINS WITH DIFFERENTIAL BINDING SCORES

Final Rejection §101§103§112
Filed
Oct 25, 2022
Priority
Oct 26, 2021 — provisional 63/271,988
Examiner
ELKINS, BLAKE HARRISON
Art Unit
1687
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
California State University Fresno
OA Round
2 (Final)
100%
Grant Probability
Favorable
3-4
OA Rounds
2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 100% — above average
100%
Career Allowance Rate
1 granted / 1 resolved
+40.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
39 currently pending
Career history
46
Total Applications
across all art units

Statute-Specific Performance

§101
25.0%
-15.0% vs TC avg
§103
29.4%
-10.6% vs TC avg
§102
10.0%
-30.0% vs TC avg
§112
21.1%
-18.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1 resolved cases

Office Action

§101 §103 §112
DETAILED ACTION The applicant’s response, from 27 July 2026, has been fully considered. Amendments to the claims and specification, from 27 July 2026, were received and entered. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status Claims 9-10 and 12 are cancelled. Claims 16-22 are newly added. Claims 1-8, 11, and 13-22 are currently pending and under examination herein. Claims 1-8, 11, and 13-22 are rejected. Priority The instant application claims priority to U.S. Provisional Application 63271988 filed 26 October 2021. In this action, claims 1-8, 11, and 13-22 are examined as though they had an effective filing date of 26 October 2021. In future actions, the effective filing date of one or more claims may change, due to amendments to the claims, or further analysis of the disclosure(s) of the priority application(s). Drawings The drawings filed on 25 October 2022 are accepted. Claim Objections The previously issued claim objection is withdrawn due to the amendments correcting the typographical error. Claim Rejections - 35 USC § 112 The previously issued 112(b) rejection is withdrawn due to the amendments correcting the missing information. The previously issued 112(d) rejection is withdrawn due to the amendments canceling the cited claim. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 7 and 19-22 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor regards as the invention. Claim 7 recites “subjecting each of the second subset of the intrinsically disordered conformations of the IDP to the first ensemble docking”. The generation of the second subset is described in claim 7 as “randomly sampling a second subset of the intrinsically disordered conformations”, which is interpreted to indicate there is only one second subset. It is therefore unclear what “each of the second subset” refers to as there appears to be only one. The metes and bounds of the limitation are therefore unclear rendering the claims indefinite. Claims 19-21 depend from claim 7 and thus contain the above issues due to said dependence. This rejection can be overcome by specifying what within the second subset is subjected to the docking (as in the following limitation). Claim 19 recites “wherein the second threshold is a t-test”. A t-test is not a single number put a procedure than involves many values. It is unclear with part of a t-test is acting a “threshold”. The metes and bounds of the claim are unclear rendering the claim indefinite. Claim 20 depends from claim 19 and thus inherits the above issue due to said dependence. This rejection can be overcome by specifying what value from a t-test is used as the threshold. Claim 22 recites “The method of claim 10”. Claim 10 was canceled. It is therefore unclear which claims 22 depends on. For the purposes of examination, claim 22 will be assumed to depend from claim 1. This rejection can be overcome by specifying a claim for claim 22 to depend from. Claim Rejections - 35 USC § 101 No argument was associated with the previously issued 35 USC 101 rejection. The following rejection is reiterated and modified as has been necessitated by amendment. 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-8, 11, and 13-22 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. In accordance with MPEP 2106, claims found to recite statutory subject matter (Step 1: YES) are then analyzed to determine if the claims recite any concepts that equate to an abstract idea or natural law (Step 2A, Prong 1). Claims 1-8, 11, and 13-22 are directed to a method. In the instant application, the claims recite the following limitations that equate to an abstract idea: Claim 1 recite the limitation - generating an IDP ensemble comprising a plurality of intrinsically disordered conformations of the IDP; comparing the first binding score to the second binding score to produce a differential binding score (DIBS) for each amino acid in the amino acid sequence of each of the sampled ligand interactions subjected to the first ensemble docking; and identifying binding sites on the IDP by comparing the DIBS for each said amino acid with a first threshold. Based on the broadest reasonable interpretation, generating conformations (Paragraph 0022 of published specification), comparing values to produce a value, and comparing values to thresholds encompasses equations and could practically be done by the human mind. This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. The claim also recites sampling interactions of the ligand with each of the plurality of intrinsically disordered conformations of the IDP in the IDP ensemble to produce sampled ligand interactions. Based on the broadest reasonable interpretation, sampling (i.e. selecting or screening) interactions could practically be done by the human mind. This draws the limitation to a mental process, which classifies the limitation as an abstract idea. The claim also recites subjecting each of the sampled ligand interactions to a first ensemble docking, wherein the first ensemble docking comprises a first binding run of the ligand along an amino acid sequence in an intrinsically disordered region of the IDP and produces a first binding score as a function of amino acid position for each of the intrinsically disordered conformations in the sampled ligand interactions; and subjecting each of a first plurality of interactions of the ligand with a corresponding first plurality of random coil conformations of the IDP to a control ensemble docking, wherein the control ensemble docking comprises a second binding run of the ligand along the amino acid sequence and produces a second binding score as a function of amino acid position for each of the first plurality of random coil conformations. Based on the broadest reasonable interpretation, docking (Paragraph 0026 of published specification) and score generation as a function encompasses equations. This draws the limitation to a mathematical concept, which classifies the limitation as an abstract idea. Claim 2 recites the limitation - generating the IDP ensemble comprises performing molecular dynamics simulations. Based on the broadest reasonable interpretation, molecular dynamics simulations (Paragraph 0022 of published specification) encompasses equations and could practically be done by the human mind. This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. Claim 3 recites the limitation - sampling the interactions of the ligand with each of the plurality of intrinsically disordered conformations of the IDP ensemble comprises randomly sampling a first subset of the intrinsically disordered conformations of the IDP in the IDP ensemble. Based on the broadest reasonable interpretation, sampling could practically be done by the human mind. This draws the limitation to a mental process, which classifies the limitation as an abstract idea. Claim 4 recites the limitation - wherein the plurality of intrinsically disordered conformations comprises about 1,000 conformations. This limitation specifies the sampling judicial exception of claim 3. The refined limitation indicated still represents a judicial expectation. Claim 5 recites the limitation - wherein the first subset of the plurality of intrinsically disordered conformations comprises about 100 conformations. This limitation specifies the sampling judicial exception of claim 3. The refined limitation indicated still represents a judicial expectation. Claim 6 recites the limitation - wherein subjecting each of the sampled ligand interactions to the first ensemble docking comprises 24 independent docking routines. This limitation specifies the docking judicial exception of claim 1. The refined limitation indicated still represents a judicial expectation. Claim 7 recites the limitation - randomly sampling a second subset of the intrinsically disordered conformations of the IDP in the IDP ensemble; and randomly sampling a third subset of the intrinsically disordered conformations of the IDP in the IDP ensemble. Based on the broadest reasonable interpretation, sampling could practically be done by the human mind. This draws the limitation to a mental process, which classifies the limitation as an abstract idea. The claim also recites subjecting each of the second subset of the intrinsically disordered conformations of the IDP to the first ensemble docking with the ligand along the amino acid sequence to produce a third binding score as a function of amino acid position for each of the intrinsically disordered conformations in the second subset; subjecting each of a second plurality of interactions of the ligand with a corresponding second plurality of random coil conformations of the IDP to the control ensemble docking to produce a fourth binding score as a function of amino acid position for each of the second plurality of random coil conformations; subjecting each of the third subset of the intrinsically disordered conformations of the IDP to the first ensemble docking with the ligand along the amino acid sequence to produce a fifth binding score as a function of amino acid position for each of the intrinsically disordered conformations in the third subset; subjecting each of a third plurality of interactions of the ligand with a corresponding third plurality of random coil conformations of the IDP to the control ensemble docking to produce a sixth binding score as a function of amino acid position as a function of amino acid position for each of the third plurality of random coil conformations. Based on the broadest reasonable interpretation, docking and generating a score as a function encompasses equations. This draws the limitation to a mathematical concept, which classifies the limitation as an abstract idea. The claim also recites averaging the first binding score, the third binding score and the fifth binding score to produce a first average value for each amino acid in the amino acid sequence; averaging the second binding score, the fourth binding score and the sixth binding score to produce a second average value for each amino acid in the amino acid sequence; determining a statistical significance between (i) the first, third and fifth binding scores and (ii) the second, fourth and sixth binding scores for each amino acid in the amino acid sequence; wherein: the DIBS is produced by comparing the first average value with the second average value; and identifying binding sites on the IDP further comprises comparing the statistical significance for each amino acid in the amino acid sequence with a second threshold. Based on the broadest reasonable interpretation, averaging values, determining statistical significance, and comparing values and thresholds encompasses equations and could practically be done by the human mind. This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. Claim 8 recites the limitation - the DIBS is further based on an estimated binding affinity of each first binding run and a number of times a particular amino acid in the amino acid sequence is involved in a binding event. Based on the broadest reasonable interpretation, estimating binding affinity (part of docking) encompasses equations. This draws the limitation to a mathematical concept, which classifies the limitation as an abstract idea. Claim 11 recites the limitation - generating the first plurality of random coil conformations of the IDP; and sampling interactions of the ligand with each of the first plurality of random coil conformations to produce sampled random coil-ligand interactions. Based on the broadest reasonable interpretation, generating random conformations and sampling could practically be done by the human mind. This draws the limitation to a mental process, which classifies the limitation as an abstract idea. The claim also recites subjecting each of the sampled random coil-ligand interactions to the control ensemble docking. Based on the broadest reasonable interpretation, docking encompasses equations. This draws the limitation to a mathematical concept, which classifies the limitation as an abstract idea. Claim 13 recites the limitation - wherein the molecular dynamics simulations are performed using a solvent model of water and isothermal-isobaric conditions with a pressure of 1.013 bar and a temperature of 300K. This limitation specifies the generating judicial exception of claim 1. The refined limitation indicated still represents a judicial expectation. Claim 14 recites the limitation - calculate a probability score for each amino acid residue in the first binding run. Based on the broadest reasonable interpretation, calculating the probability score encompasses equations and could practically be done by the human mind (see claim 15). This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. Claim 15 recite the limitation - wherein the probability score is calculated according to: PNG media_image1.png 51 193 media_image1.png Greyscale , where k is the amino acid position in the amino acid sequence, ni is a number of times the amino acid residue at the amino acid position k encounters the ligand, N is a total number of first binding runs in the first ensemble docking, and DCi is a corresponding dissociation constant. Based on the broadest reasonable interpretation, calculating the probability score encompasses equations and could practically be done by the human mind. This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. Claim 16 recites the limitation - measuring a binding constant of the ligand and each of the plurality of intrinsically disordered conformations of the IDP. Based on the broadest reasonable interpretation, measuring the binding constant encompasses equations (part of docking/simulation). This draws the limitation to a mathematical concept, which classifies the limitation as an abstract idea. Claim 17 recite the limitation - wherein the first subset of the plurality of intrinsically disordered conformations comprises about 100 conformations. This limitation specifies the sampling judicial exception of claim 3. The refined limitation indicated still represents a judicial expectation. Claim 18 recites the limitation - wherein the first threshold is a fold change. This limitation specifies the identifying judicial exception of claim 1. The refined limitation indicated still represents a judicial expectation. Claim 19 recites the limitation - wherein the second threshold is a t-test or a p-value. This limitation specifies the identifying judicial exception of claim 7. The refined limitation indicated still represents a judicial expectation. Claim 20 recites the limitation - wherein the first threshold is a log2 fold change of 2.0 the second threshold is a p-value < 0.05. This limitation specifies the identifying judicial exceptions of claims 1 and 7. The refined limitation indicated still represents a judicial expectation. Claim 21 recite the limitation - plotting the DIBS against the statistical significance for each amino acid residue in the amino acid sequence. Based on the broadest reasonable interpretation, plotting data could practically be done by the human mind. This draws the limitation to a mental process, which classifies the limitation as an abstract idea. The claim also recites identifying the binding sites on the IDP among the amino acid residues in which the DIBS exceeds the first threshold and the statistical significance is below the second threshold. Based on the broadest reasonable interpretation, comparing values and thresholds encompasses equations and could practically be done by the human mind. This draws the limitation to a mathematical concept and a mental process, which classifies the limitation as an abstract idea. Claim 22 recites the limitation - wherein the IDP is an enzyme. This limitation specifies the information in the generating judicial exception of claim 1. The refined limitation indicated still represents a judicial expectation. These limitations recite concepts of generating, calculating, selecting, and comparing information and values and relying on mathematical simulations that are so generically recited that they can be practically performed in the human mind as claimed, which falls under the “Mental processes” and “Mathematical concepts” grouping of abstract ideas. A mathematical concept need not be expressed in mathematical symbols, because words used in a claim operating on data to solve a problem can serve the same purpose as a formula (MPEP 2106.04(a)(2)). Additionally, both product claims and process claims may recite mental processes, which can include a claim that requires a computer (MPEP 2106.04(a)(2)). The published specification indicates many of the recited limitations can be performed by utilizing software which are algorithm based, indicating the interpretation of claims encompass require algorithm based data generation (Paragraph 0022: Ensemble of conformations were generated using molecular dynamics simulations performed using the academic implementation Desmond combined with the user interface for visualization Schrödinger's Maestro; Paragraph 0026: The molecular docking protocols were performed using the Autodock VINA, with the default parameters implemented within YASARA (version 19.1.27) molecular modeling program), which is an abstract idea. Also, claim 15, which describes aspects of the docking, recites an equation. Therefore, these limitations fall under the “Mental process” and “Mathematical concepts” groupings of abstract ideas. As such, claims 1-8, 11, and 13-22 recite an abstract idea (Step 2A, Prong 1: YES). Claims found to recite a judicial exception under Step 2A, Prong 1 are then further analyzed to determine if the claims as a whole integrate the recited judicial exception into a practical application or not (Step 2A, Prong 2). These judicial exceptions are not integrated into a practical application because the claims do not recite an additional element that reflects an improvement to technology (MPEP § 2106.04(d)(1)). Rather, the claims provide insignificant extra-solution activity (MPEP § 2106.05(g)) and provide mere instructions to apply a judicial exception (MPEP § 2106.05(f)). Specifically, the claims recite the following additional elements: Claim 1 recites a computer and one or more non-transitory or non-volatile tangible computer-readable media. Claim 2 recites the computer and at least a first one of the one or more non-transitory or non-volatile tangible computer-readable media. Claim 3 recites the computer and at least a second one of the one or more non-transitory or non-volatile tangible computer-readable media. Claim 7 recites the computer and the one or more non-transitory or non-volatile tangible computer-readable media. Claim 11 recites the computer and the one or more non-transitory or non-volatile tangible computer-readable media. Claim 14 recites the computer and the one or more non- transitory or non-volatile tangible computer-readable media. Claim 16 recites the computer and the one or more non-transitory or non-volatile tangible computer-readable media. Claim 21 recites the computer and the one or more non-transitory or non-volatile tangible computer- readable media. There are no limitations that indicate that the claimed generating, calculating, selecting, and comparing information and values and relying on mathematical simulations require anything other than generic computing systems. The recited additional elements are interpreted as generic computing systems (processing and memory). As such, these limitations equate to mere instructions to implement the abstract idea on a generic computer that the courts have stated does not render an abstract idea eligible. It is unclear how the limitations of the instant application would specifically result in Improvements in the Functioning of a Computer, or an Improvement to Any Other Technology or Technical Field under MPEP 2106.04(d)(1). There is no indication that these steps are affected by the judicial exception in any way and thus do not integrate the recited judicial exception into a practical application. As such, claims 1-8, 11, and 13-22 are directed to an abstract idea (Step 2A, Prong 2: NO). Claims found to be directed to a judicial exception are then further evaluated to determine if the claims recite an inventive concept that provides significantly more than the judicial exception itself (Step 2B). The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claims recite conventional additional elements that equate to mere instructions to apply the recited exception in a generic way or in a generic computing environment. As discussed above, there are no additional limitations to indicate that the claimed generating, calculating, selecting, and comparing information and values and relying on mathematical simulations require anything other than generic computer components in order to carry out the recited abstract idea in the claims. Claims that amount to nothing more than an instruction to apply the abstract idea using a generic computer do not render an abstract idea or natural law eligible. MPEP 2106.05(f) discloses that mere instructions to apply the judicial exception cannot provide an inventive concept to the claims. As specified in MPEP 2106.05(g), extra-solution activities can be understood as incidental to the primary process or product that are merely a nominal or tangential addition to the claim. Insignificant extra-solution activities include mere data gathering, selecting a particular data source or type of data to be manipulated, and displaying information. Additionally, Ciemny et al. (2019, International Journal of Molecular Sciences, Vol 20: 1-15) teach that using computers to study intrinsically disordered proteins, including simulations and docking, is well-understood, routine, and conventional (Page 7, Paragraph 1: numerous programs can be accessed through the web or as standalone applications). Additionally, the published specification indicate numerous consumer products used to complete the methods (Paragraph 0022: Ensemble of conformations were generated using molecular dynamics simulations performed using the academic implementation Desmond combined with the user interface for visualization Schrödinger's Maestro; Paragraph 0026: The molecular docking protocols were performed using the Autodock VINA, with the default parameters implemented within YASARA (version 19.1.27) molecular modeling program) which further illustrate the conventional nature of using a computer for the recited methods. The additional elements do not comprise an inventive concept when considered individually or as an ordered combination that transforms the claimed judicial exception into a patent-eligible application of the judicial exception. Therefore, the claims do not amount to significantly more than the judicial exception itself (Step 2B: No). As such, Claims 1-8, 11, and 13-22 are not patent eligible. Claim Rejections - 35 USC § 103 The previously issued 103 rejecting is withdrawn in response the amended claims drastically altering the scope the claimed invention. Additionally, Applicant’s arguments regarding how the teachings of random coils present in the art differed from the utilization of conformations of random coils in the amended claims was considered persuasive (Page 15, Paragraph 3 of remarks). The instant claims are considered to be free of the prior art. The most relevant prior art is considered to be Ruan et al. (2021, Chemical Science, Vol. 12: 1-31). Regarding Claim 1 (independent claim), Ruan et al. teach generating an IDP ensemble comprising a plurality of intrinsically disordered conformations of the IDP; sampling interactions of the ligand with each of the plurality of intrinsically disordered conformations of the IDP in the IDP ensemble to produce sampled ligand interactions (Page 8, Column 1, Paragraph 2: To sample p53 TAD1 conformations, classical all-atom MD and REMD simulations were performed). Ruan et al. suggest subjecting each of the sampled ligand interactions to a first ensemble docking, wherein the first ensemble docking comprises a first binding run of the ligand along an amino acid sequence in an intrinsically disordered region of the IDP and produces a first binding score as a function of amino acid position for each of the intrinsically disordered conformations in the sampled ligand interactions (Page 3, Column 2, Paragraph 1: docking scores of the eight conformations; Page 8, Column 2, Paragraph 3: Ensemble based docking was conducted using the selected eight conformations). Ruan et al. do not teach the score is related to an amino acid position. Ruan et al. teach the use of random coil conformations as a baseline (Page 8, Column 1, Paragraph 2) but do not use them to generate a control group. The lack of an ensemble of random coil conformations functioning as a control group to generate a score to compare could be remedied by additional art. Ruan et al. teach the use of specific molecules with defined conformations to function as their control (Page 7, Column 1, Paragraph 4: To further test our computational strategy, we performed negative control experiments. We purchased ten single conformation binding compounds and tested their binding strength with p53 TAD1). Ruan et al. suggest the comparison of average binding values between experimental and control groups (Page 27, Supplemental Table S4). Regarding the dependent claims, Ruan et al. teach Claim 2 (Page 8, Column 1, Paragraph 2: To sample p53 TAD1 conformations, classical all-atom MD and REMD simulations were performed) and Claim 3 (Page 8, Column 1, Paragraph 2: Each replica started from the same structure but with different random number seeds). Claim 7 is interpreted as repeating the control and experimental docking with two additional samplings (i.e. produce 3 replicates for each group). Replicating in triplicate is suggested by Ruan et al. (Page 8, Column 1, Paragraph 2: Three simulations were conducted). Ruan et al. does not teach the final (DIBS) score is based on a comparison between the control and experimental groups using a statistical difference. Ruan et al. also suggest the conditions described in claim 13 (Page 8, Column 1, Paragraph 2: Three 300 ns simulations were conducted in the NPT (P = 1 atm and T = 298 K) ensemble). Ruan et al. does not teach calculating probability score as part of the docking (Claim 14). This deficiency extends to the specific formula and assemblage of variables used to calculate the probability score (Claim 15), which could not be to remedied by additional art. Ruan et al. also does not teach the remaining undiscussed dependent claims (specific values for number of runs, conformations, or thresholds). Na et al. (2020, International Journal of Molecular Sciences, Vol, 21: 1-16) is also relevant to the recited methods of the instant application and remedies some deficiencies of Ruan et al. Na et al. teaches the use statistical of tests and thresholds to compare binding of different groups, including disordered proteins, based on molecular docking. However, Na et al. does not teach the specific thresholds or comparisons recited by the instant application or remedy the deficiencies of the independent claim (Claim 1). Chong et al. (2020, Journal of Chemical and information Modleing, Vol. 60: 1-8) is also relevant to the recited methods of the instant application and remedies some deficiencies of Ruan et al. Chong et al. calculates binding scores for conformations of disordered proteins, based on molecular docking. However, Chong et al. does not teach the specific thresholds, comparisons, or calculations recited by the instant application or remedy the deficiencies of the independent claim (Claim 1). Even if one of ordinary skill in the art was motivated to the combine these references, they would not teach or make obvious all of the limitations recited by the instant claims. Therefore, the claims are considered to be free of the prior art. Double Patenting No double patenting rejections are issued. Conclusion No claims are allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BLAKE H ELKINS whose telephone number is (571)272-2649. The examiner can normally be reached Monday-Thursday 8-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Karlheinz Skowronek can be reached at (571) 272-9047. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /B.H.E./Examiner, Art Unit 1687 /Karlheinz R. Skowronek/Supervisory Patent Examiner, Art Unit 1687
Read full office action

Prosecution Timeline

Oct 25, 2022
Application Filed
Apr 07, 2026
Non-Final Rejection mailed — §101, §103, §112
Jul 27, 2026
Response Filed
Oct 19, 2026
Final Rejection mailed — §101, §103, §112 (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
100%
Grant Probability
99%
With Interview (+0.0%)
4y 2m (~2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month